National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 
 
Results: 1 -10 of 29    Show     results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

   
Phase III

   
COG-AALL0232
NCT00075725, AALL0232

 
 
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

   
Phase III

   
COG-AALL0331
AALL0331, NCT00103285

 
 
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma

   
Phase III

   
MCC-0402
NCT00369564, ACCL 0731

 
 
Pegasparaginase or Asparaginase and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

   
Phase III

   
DFCI-05001
NCT00400946

 
 
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

   
Phase III

   
COG-AALL0434
AALL0434, NCT00408005

 
 
Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers

   
Phase III

   
418
BMTCTN-0201, NCT00075816

 
 
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

   
Phase III

   
2004-0107
NCT00500240

 
 
Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

   
Phase III

   
COG-AALL0631
AALL0631, NCT00557193

 
 
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

   
Phase III

   
TOTXVI
NCT00549848

 
 
Phase I/II Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

   
Phase II, Phase I

   
UMCC 2007.055
NCT00556452

 
      1 2 3   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov